Human liver alcohol dehydrogenase (alcohol: NAD+ oxidoreductase, EC 1.1.1.1) catalyzes the oxidation of the 3d-OH group of digitoxigenin, digoxigenin, and gitoxigenin to their 3-keto derivatives, which have been characterized by high-performance liquid chromatography and mass spectrometry. These Our earliest kinetic studies of partially purified human liver alcohol dehydrogenase (LADH; alcohol:NAD+ oxidoreductase, EC 1.1.1.1) showed its broad substrate specificity (1), encompassing, inter alia, aldehydes, primary and secondary aliphatic and aromatic alcohols, polyenoates, and sterols.
ogy, and toxicology of ethanol and these glycosides, structurally unrelated agents that are both used widely. Both the competition of ethanol with these cardiac sterols and the narrow margin of safety in the therapeutic use of digitalis derivatives would seem to place at increased risk those individuals who receive digitalis and simultaneously consume large amounts of ethanol or whose alcohol dehydrogenase function is impaired.
Our earliest kinetic studies of partially purified human liver alcohol dehydrogenase (LADH; alcohol:NAD+ oxidoreductase, EC 1.1.1.1) showed its broad substrate specificity (1), encompassing, inter alia, aldehydes, primary and secondary aliphatic and aromatic alcohols, polyenoates, and sterols.
We have found recently that highly purified human LADH inactivates digoxin, digitoxin, and gitoxin, glycosides employed widely in the treatment of cardiac failure. Specifically, human LADH catalyzes the oxidation of the 33-OH group of digoxigenin, digitoxigenin, and gitoxigenin, the genins of digoxin, digitoxin, and gitoxin, to their 3-keto derivatives.
The 3 position of these sterols has proven to be an important site of enzymatic transformation (2) , long thought to be under control of an unknown enzyme (3) . After oxidation of the Sf3-OH group of the genins, cardiac activity is decreased by more than 90%. Moreover, LADH is the only cytosolic enzyme in human liver, the known site of genin metabolism, to catalyze this oxidation, which is the first major step in the abolition of the pharmacological action of these cardiac glycosides. Subsequent enzymatic conversion of the 3-keto to the 3a-OH group abolishes activity. The participation of human LADH in the oxidation of ethanol and of the genins, the active principles of digitalis, has important biochemical, therapeutic, and toxicological implications because it establishes a direct link between the metabolisms of these important drugs. The finding is a result of our efforts to delineate the substrate specificities, to identify and characterize the human isoenzymes, and to further explore the biochemical basis for the metabolism and pathology of ethanol.
METHODS
Human LADH, homogeneous by sodium dodecyl sulfate/ polyacrylamide gel electrophoresis and ultracentrifugation but composed of multiple isoenzymes, was purified by double ternary complex affinity chromatography (4). Protein concentration was calculated from absorbance at 280 nm, using a value of A°201= 0.58 (5 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. The values for the oxidation products were identical with those of the authentic 3-keto derivatives (7). The mass spectra of the oxidation products and those of the authentic samples were identical and verified the structure as that of the 3-keto sterols (Fig. 1) .
A number of approaches have confirmed that both ethanol and these cardiac sterols interact at the same site on human LADH. First, the chelating agents 1,10-phenanthroline, a,a'-bipyridine, and EDTA inhibited the oxidation of ethanol and of these sterols in exactly the same fashion (Table 2) . Thus, 1,10-phenanthroline inhibited the oxidation of both ethanol and digitoxigenin instantaneously and reversibly, indicating formation of a ternary enzyme-metal-chelator complex (8 (Fig. 2) . The number of moles of inhibitor bound per active site, n, is consistent with this mode of inhibition (9) . On the other hand, a,a'-bipyridine and EDTA, which also inhibited the oxidation of both substrates by human LADH, did so in a time-dependent irreversible manner, in line with past observations (5, 8) . This mode of inhibition is thought to be due to metal removal by the chelating agent (10) . Second, studies with nonchelating inhibitors that compete with ethanol showed that they also compete with these genins. Thus, 4-methylpyrazole is specific and selective for this and other alcohol dehydrogenases (4); it competitively inhibited the oxidation of digitoxigenin with a Ki of t0.9 IuM (Fig. 3) , which can be compared with the Ki of t1 gM for ethanol oxidation (5) . Again (4) , has broader substrate specificity and greater polymorphism than found for the corresponding enzyme from other species, including that of horse liver. The substrate specificity of the three major horse isoenzymes has been studied extensively and has led to their classification by Theorell as being ethanol-active (EE), steroid-active (SS), or active towards both (ES) (11) . In particular, the activity of the horse SS isoenzyme is apparently directed towards sterols. All molecular forms of the human enzyme inspected thus far seemingly share this property (12) . We (2) . Thus, human LADH is the hitherto unknown enzyme (3) that performs the important first and major step abolishing the activity of digitalis-i.e., the oxidation of digoxigenin and digitoxigenin to the corresponding 3-keto derivatives (Fig. 4) 
